The following post provides information and NON-MEDICAL advice I've come across that I'll be presenting to my oncologist tomorrow. I thought it might be of value for others among us to consider, to further research (I provide citations), to comment on, and/or to speak to their doctor(s) and oncologist about. Bless you all and, most especially, the wonderful administrators who devote so much of their lives to helping us find a better place to be!
In my readings, I’ve come across a number of sites I consider valuable with regard to the possibility of treating me (and possibly others). I would sincerely appreciate your reviewing the information below (and possibly the cited sites), and letting me know if you believe we can move forward with any of these as possible supplemental treatments.
* A general conclusion of mine, from what I’ve read, is that anything that both induces apoptosis and appears to have a direct beneficial effect on CLL, as noted in these and many other studies, could help by reducing my dosage of any targeted therapy treatment and also minimizing my adverse reactions. Therefore, I would like to know:
—Do you agree, with this statement?
—Do you believe that any of the belowmentioned items could be used to supplement my therapy and, if so, which?
—Are you aware of any other possible natural supplements that could be similarly beneficial?
—If you believe that it might be of value to try this approach, and as right now I seem to be tolerating the 140mg dose [down from 280mg], could we try one or more such supplement, while at the same time reducing my dose to 70mg?
—NB: You do NOT need to provide any answers during this appointment. However, I would appreciate a response, if possible, within the next two weeks. Thank you!
*** “In checking for the ability to kill the cancer cells it was found that Reishi [G. lucidum] caused the destruction of the myeloma (U937 cells, RPM18226 cells), leukemia (HL-60), and lymphoma (Blin-1 cells) cells assessed for this from 21% to 92%. — Reishi Mushroom causes the destruction of leukemia, lymphoma, and multiple myeloma cells —invitehealth.com/reishi-mus... — Abstract: “…”These results indicate that G. lucidum extract has a profound activity against leukemia, lymphoma and multiple myeloma cells.” — Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells — pubmed.ncbi.nlm.nih.gov/164...
*** “…our results suggest that cordycepin possesses a synergistic cytotoxic effect with Cordyceps militaris-mediated apoptosis in human leukemia cells…” — Synergistic property of cordycepin in cultivated Cordyceps militaris-mediated apoptosis in human leukemia cells — doi.org/10.1016/j.phymed.20...
*** “Combined treatment with the medicinal mushroom Ganoderma lucidum and the herb Duchesnea chrysantha extracts (GDE) causes a synergistic induction of mitochondrial damage and apoptosis in HL-60 cells. GDE treatment is selectively toxic to HL-60 leukemia cells whereas no cytotoxic effect is observed in normal peripheral blood mononuclear cells.” — Enhanced induction of mitochondrial damage and apoptosis in human leukemia HL-60 cells by the Ganoderma lucidum and Duchesnea chrysantha extracts — doi.org/10.1016/j.canlet.20...
*** * “Shiitake mushrooom, Lentinulaedodes produces lentinan, a β-glucan known to suppress leukemia cell proliferation.…Treatment with cordycepin from C. militaris significantly inhibited human leukemia cell growth in a concentration-dependent manner by inducing apoptosis.…Fruiting body [of a novel edible mushroom, Pleurotustuber-regium] extract showed the strongest cytotoxicity (approximate IC50 25 μg/mL) and exerted effective anti-proliferative activity at 200 μg/mL against human acute promyelocytic leukemia cells (HL-60).…” Recent developments in mushrooms as anti-cancer therapeutics: a review, — 3 Biotech. 2012 Mar; 2(1): 1–15. Published online 2011
*** “ A…2017 study tested Artemisia extract against K562 and HL-60 human leukemia cells. This study found the Artemisia extract killed the leukemia cells of both types within 48 hours of contact. …The researchers found…Artemisia absinthium killed 75 percent of the leukemia cells, with 70 percent killed within the first 48 hours.” — Artemisia Herb Inhibits Growth of Multiple Cancers — JOURNAL OF PLANT MEDICINES | ISSN 2689-4548 | CURRENT ISSUE: VOL. 7. NO. 2, 2017
*** “It is known that RSV [resveratrol]: may exert its activity on human PBMCs in a bi-phasic/dose-dependent way; is cytotoxic to lymphoma and leukemia cancer cells since it can trigger apoptosis, autophagy or senescence…” — The Multiple Mechanisms of Cell Death Triggered by Resveratrol in Lymphoma and Leukemia, Int J Mol Sci. 2014 Mar; 15(3): 4977–4993. Published online 2014 Mar 20
*** “There is accumulating evidence that green tea extract EGCG [(-)-epigallocatechin-3-gallate] may exert a preventive or a direct anti-tumor effect in several tumor types including chronic lymphocytic leukemia (CLL).…These data suggest that EGCG exerts a pro-apoptotic effect and activates other cell killing mechanisms in CLL cells.” — Green Tea Extract EGCG Induces Apoptosis in CLL Cells and Overcomes the Supportive Effect of Primary Bone Marrow Stromal Cells Through the Regulation of PI3K/Akt Cascade and Proteasome Activity, 641. CLL - BIOLOGY AND PATHOPHYSIOLOGY, EXCLUDING THERAPY: POSTER III| NOVEMBER 16, 2012
*** “…patients with CLL benefit from curcumin due to its immunopotentiator properties resulting in protection from infectious diseases [CLL] [19]…Curcumin…also…induces micronuleation and apoptosis…Kao, et al…observed that curcumin was capable of inducing apoptosis in promyelocytic leukemia HL-60 cells at low concentrations of 3.5ug/ml.…Curcumin…is beneficial in leukemia, especially in early stages of CLL It prevents the progression of the disease, decreases CLL B-cell counts, and, also when administered together with conventional anti-cancer drugs, has synergistic actions, in addition to lowering their dose and side effects.” — Curcumin in chronic lymphocytic leukemia – A review — Asian Pacific Journal of Tropical Biomedicine, Volume 7, Issue 6, June 2017, Pages 505-512
*** “In summary, we found that H2O2 preferentially affects leukemic cells by decreasing their viability, quiescent state and clonogenic capability via the modulation of survival signaling through decreased AKT activity. From a clinical point of view, treatments based on the ROS modulation levels are a promising therapeutic tool, once the redox state-induced alterations can cause selective hematopoietic cell fate, sensitizing leukemic cells to death.” — Hydrogen peroxide (H2O2) induces leukemic but not normal hematopoietic cell death in a dose-dependent manner — Cancer Cell International volume 13, Article number: 123 (2013)
* Cancer Cell International volume 13, Article number: 123 (2013)
*** “The present findings indicate that Antho 50 [from bilberry] exhibits strong pro-apoptotic activity through redox-sensitive caspase 3 activation-related mechanism in B CLL cells involving dysregulation of the Bad/Bcl-2 pathway. This activity of Antho 50 involves the glucoside and rutinoside derivatives of delphinidin. They further suggest that Antho 50 has chemotherapeutic potential by targeting selectively B CLL cells.” — Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway — Sci Rep. 2015; 5: 8996. Published online 2015 Mar 11.
*** “In summary, we found that H2O2 preferentially affects leukemic cells by decreasing their viability, quiescent state and clonogenic capability via the modulation of survival signaling through decreased AKT activity. From a clinical point of view, treatments based on the ROS modulation levels are a promising therapeutic tool, once the redox state-induced alterations can cause selective hematopoietic cell fate, sensitizing leukemic cells to death.” — Hydrogen peroxide (H2O2) induces leukemic but not normal hematopoietic cell death in a dose-dependent manner — Cancer Cell International volume 13, Article number: 123 (2013)
* Cancer Cell International volume 13, Article number: 123 (2013)